Most stocks broadly reflect a combination of their underlying company’s current value and future prospects. As that value and those prospects evolve over time, so does a stock’s price.
Biotech stocks aren’t “most stocks,” however.
In the world of biotech, a stock’s value is largely dependent on the success or failure of one particular drug. That’s why biotech stocks are notorious for soaring or plunging in just one day — because one announcement can instantaneously make or break a stock’s value.
Of course, if you’re in the right side of the news, a quick fortune can be made.
With that in mind, here are five biotech stocks with catalytic decisions or news scheduled for the near-term future.